Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Novavax Inc (NVAX)

NASDAQ
Currency in USD
Disclaimer
4.115
+0.165(+4.18%)
Real-time Data

NVAX Comments

I just bought more 40k worth of nvax stock. I am not selling until it hits at least 200, even then I think it is still undervalued. I really think fda will approve nanoflu anytime soon. Its currently under accelerated review after meeting all its phase 3 endpoints. Also covid-19 vaccine in phase 3, rsv vaccine in its pipeline, no rsv vaccine was ever approved yet. Then if we can get combined covid/nanoflu in one shot. Likely covid 19 will become seasonal just like flu. No other vaccine conpamy is in a better position to profit from this pandemic then nvax. Just my rationale
my personal tp is 300 usd I agree on all the rest
 Ted_Investing is creating a disterssing time on this chat with his random comments...
agree, we dont need that. He can keep his negative ideas/feelings to himself, we are not interested
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.